Press release
Verastem Oncology to Present at the RBC Capital Markets Global Healthcare Conference
BOSTON--(BUSINESS WIRE)-- Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today
About this update from Verastem, Inc.
[{"type":"text","content":" BOSTON--(BUSINESS WIRE)--\nVerastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that its management team will participate in a fireside chat at the 2024 RBC Capital Markets Global Healthcare Conference in New York on Tuesday, May 14, 2024 at 3:35 pm EDT.\n\n\nA live webcast of the fireside chat can be accessed under events on the Verastem Oncology’s website at www.verastem.com. A replay of the webcast will be archived on the website for approximately 90 days following the presentation.\n\n\nAbout Verastem Oncology\n\n\nVerastem Oncology (Nasdaq: VSTM) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on RAS/MAPK-driven cancers, specifically novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and FAK inhibition. For more information, please visit www.verastem.com and follow us on LinkedIn.\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20240507625461/en/\n\nFor Investor and Media Inquiries:\nJulissa Viana\nVice President, Corporate Communications and Investor Relations\[email protected] or\[email protected]\n\n\nSource: Verastem Oncology","length":2967,"tagName":"div"}]